|
|
Post by promann on Jan 17, 2017 9:54:53 GMT -5
I find Jay to be a very intelegent guy in a field that is very demanding! I would think with his background with digital marketing he could get a job anywhere not just in pharma. I ask myself why did he choose MNKD, and the only answer is because MNKD pursued him and not the other way around or perhaps there is something fishy with Amagen it does smell rather paculiar. Very interesting to say the least
|
|
|
|
Post by derek2 on Jan 17, 2017 10:13:07 GMT -5
And maybe they like where they live and don't want to move. Valencia is close to Thousand Oaks. Brentie, What is the official address of The West Coast office? Know that we have a contract to sell the Valencia building, are we going to lease a small amount of space in that building or be relocated to another address? What is that address. MannKind Corporation Headquarters 25134 Rye Canyon Loop Suite 300 Valencia, CA 91355 (661) 775-5300 About a mile away from the office that has been sold. |
|
|
|
Post by brentie on Jan 17, 2017 10:17:51 GMT -5
And maybe they like where they live and don't want to move. Valencia is close to Thousand Oaks. Brentie, What is the official address of The West Coast office? Know that we have a contract to sell the Valencia building, are we going to lease a small amount of space in that building or be relocated to another address? What is that address. Sorry, KC, I can't give you the address. MannKind just has it listed as Valencia. Maybe someone who lives nearby could help you. www.mannkindcorp.com/about-us/locations/As to the second part of your post, I don't believe they have to relocate because they stated a year ago that the building was already vacant then. "We do have some other non-critical assets. I think it’s fairly well known that we had a facility we opened in Valencia, California, which was now vacant and on the market for sale, which could raise some money." ( To find this quote, put the word "vacant " in the "search this transcript box" on the right side of the page.) seekingalpha.com/article/3809206-mannkinds-mnkd-ceo-matt-pfeffer-presents-34th-annual-jpmorgan-healthcare-conference |
|
|
|
Post by cyn on Jan 17, 2017 10:48:40 GMT -5
cm5, Thanks for posting the bio article on Jay Appel. Very impressive. www.pm360online.com/elite-digital-crusader-jay-appel-of-amgen/ I found the following excerpts particularly interesting. Excerpt... "His long list of accomplishments includes leading the launch of Amgen’s first patient-facing branded app in the U.S. This optional digital companion supports patients (and their caregivers) using Amgen’s unique on-body injector....Additionally, he wants to find ways to leverage the learnings of digital engagement from the commercial setting so development partners have digital options at their disposal to foster faster trial recruitment and improved trial retention." This is exactly what Afrezza needs to address market penetration and paradigm shifting challenges. A digital companion App will help alleviate both patient and Endo reluctance over new medication regime changes, while also providing just in time dosage support and patient education. |
|
|
|
Post by od on Jan 17, 2017 10:59:07 GMT -5
Who was it that said if 3 people from Amgen management get hired by MannKind then it's definately a buyout by Amgen. Not that I believe it but somebody on this board mentioned it. Just funny that now there are 3 I hope Mr. Appel designs and executes an exquisite digital strategy, but....he was not part of Amgen 'management'. |
|
|
|
Post by brotherm1 on Jan 17, 2017 11:30:34 GMT -5
I don't recall this position filled by Jay, nor can I recall the human rescource position recently filled by an Amgen employee having ever been advertised? Does anyone else know if these positions were posted?
|
|
|
|
Post by gamblerjag on Jan 17, 2017 11:32:59 GMT -5
Well if there is a buyout soon which I don't think is in the cards.. this would be epic and embarrassment of riches from this price.... because IMO this will not sell less than 8 billion.. or about $17 pps... that would be epic from these prices.. but don't think that is what's going on here. Also, volume would be higher.. if a message board, ST etc are catching this 3rd employee joining MNKD, I would think business writers would be all over this by now...
|
|
|
|
Post by gamblerjag on Jan 17, 2017 11:34:14 GMT -5
Kuka, I'm guessing .. it means that Mike C has confidence in these two new gents and the two new gents knows what MNKD has.. nothing more
|
|
|
|
Post by brotherm1 on Jan 17, 2017 11:40:06 GMT -5
cm5, Thanks for posting the bio article on Jay Appel. Very impressive. www.pm360online.com/elite-digital-crusader-jay-appel-of-amgen/ I found the following excerpts particularly interesting. Excerpt... "His long list of accomplishments includes leading the launch of Amgen’s first patient-facing branded app in the U.S. This optional digital companion supports patients (and their caregivers) using Amgen’s unique on-body injector....Additionally, he wants to find ways to leverage the learnings of digital engagement from the commercial setting so development partners have digital options at their disposal to foster faster trial recruitment and improved trial retention." This is exactly what Afrezza needs to address market penetration and paradigm shifting challenges. A digital companion App will help alleviate both patient and Endo reluctance over new medication regime changes, while also providing just in time dosage support and patient education. cyn, this is very interesting but unfortunately it's above my medical and technical level of comprehension. Any chance you could please elaborate in laymen's language what this means and how such programming would work? |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 17, 2017 11:40:32 GMT -5
but Kuka has the talent to put all the small pieces of information together for the big picture. So I believe him.
|
|
|
|
Post by sweedee79 on Jan 17, 2017 12:00:52 GMT -5
Hmm.....admin closed my last thread which is still VALID but I dont hold a Grudge ... Jason Appel is now at MNKD That makes 3 AMGEN guys that moved over to MNKD ..... Hmmmmm what could that mean? That Amgen is a lousy place to work or is laying off staff? Seriously - it means nothing other than three people from Amgen now work at Mannkind. Of course no one knows what it means..... but it is certainly relevant... so I don't understand the constant dissent... |
|
|
|
Post by akemp3000 on Jan 17, 2017 12:20:16 GMT -5
With his strong digital background, this is clearly a good and important hire. While all of us can guess if it might have further meaning, one fact we do know is that Amgen is now aware that they are losing some highly talented and industry respected people to MNKD. This is very good news!
|
|
|
|
Post by madog365 on Jan 17, 2017 13:10:55 GMT -5
With his strong digital background, this is clearly a good and important hire. While all of us can guess if it might have further meaning, one fact we do know is that Amgen is now aware that they are losing some highly talented and industry respected people to MNKD. This is very good news! Agree! Digital marketing is so important these days, i'm very happy they are finally investing in talent there. I hope the next area they will hire will be PR - the company is severely lacking there. Keep in mind, now that the previous Amgen HR head is with Mannkind, we may see even more of his contacts from Amgen filling Mannkind roles. It's all about connections in any industry - This type of movement does not have to be indicative of a buyout or acquisition. |
|
|
|
Post by rockstarrick on Jan 17, 2017 13:37:19 GMT -5
Amazing, another marketing guy. This one specialized in data-based marketing. IMO these guys have a lot of attractive alternatives to go to if Amgen is really such a lousy company. Why did they chose MNKD? Same reason Mike did. They have nothing to lose. Get loaded up with options and if MNKD does succeed they will cash out big time and have this turn around on their resume for what ever job they want going forward. If MNKD doesn't succeed they go back to mid/large corporate and the first item they discuss in interview is how MNKD was a financial mess before they even got there. The gamble is almost once in a lifetime and worth it. "The gamble is almost once in a lifetime and worth it" This is exactly how I feel about my investment in Mannkind. I honestly feel that I am invested in the most significant improvement to the treatment of Diabetes since the discovery of insulin. Everybody has the right to their own opinions, this is mine. Cheers kbrion |
|
|
|
Post by dreamboatcruise on Jan 17, 2017 13:58:28 GMT -5
cm5, Thanks for posting the bio article on Jay Appel. Very impressive. www.pm360online.com/elite-digital-crusader-jay-appel-of-amgen/ I found the following excerpts particularly interesting. Excerpt... "His long list of accomplishments includes leading the launch of Amgen’s first patient-facing branded app in the U.S. This optional digital companion supports patients (and their caregivers) using Amgen’s unique on-body injector....Additionally, he wants to find ways to leverage the learnings of digital engagement from the commercial setting so development partners have digital options at their disposal to foster faster trial recruitment and improved trial retention." This is exactly what Afrezza needs to address market penetration and paradigm shifting challenges. A digital companion App will help alleviate both patient and Endo reluctance over new medication regime changes, while also providing just in time dosage support and patient education. There isn't any magic in having information available in an app format. The information presented on dosing would basically have to be the same as is currently in the FDA prescribing literature. Perhaps it could be an effective route for having patients interact with the Afrezza helpline, as alternative to old fashioned phone... but I doubt in the short run there would really be anything game changing with regard to doctor or patient acceptance. |
|
